Travere Therapeutics Inc. diskutieren
Travere Therapeutics Inc.
WKN: A2QHYP / Symbol: RTRX / Name: Travere Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
20,60 €
0,98 %
Gesundheit | Arzneimittelhersteller - Wichtige | Vereinigte Staaten
a +
(Vom Mitglied beendet)
Retrophin mit FDA-Zulassung zur Behandlung von Cystinurie und
fortgeschrittener pipeline:
Sell mit Kursziel 10,0
Buy Retrophin Inc.
Buy Retrophin Inc.
Buy Retrophin Inc.
Buy Retrophin Inc.
Sell Retrophin Inc.
Sell Retrophin Inc.
Sell Retrophin Inc.
Sell Retrophin Inc.
Sell Retrophin Inc.
Buy Travere Therapeutics Inc.
The Calm Slide offers a fuss-free slip-on experience with its Nike Dunks Reps. Constructed using pliable foam, this simple sandal boasts a wide, comfy strap on the upper embellished with debossed along its side
The shoe pays homage to the Fake SB Dunks, capturing the essence of the season’s legends. Don’t miss out on this unique and eerie footwear option.
Get ready to celebrate Halloween 2023 in style with Nike Skateboarding’s highly anticipated release: a special edition of their beloved
Neueste Beiträge
Bankster in Biodexa Pharmaceuticals Plc diskutieren